Naturally Acquired Antibody Response to Malaria Transmission Blocking Vaccine Candidate Pvs230 Domain 1

Naturally Acquired Antibody Response to Malaria Transmission Blocking Vaccine Candidate Pvs230 Domain 1

Plasmodium vivax malaria incidence has increased in Latin America and Asia and is responsible for nearly 74.1% of malaria cases in Latin America. Immune responses to P. vivax are less well characterized than those to P. falciparum, partly because P. vivax is more difficult to cultivate in the labora...

Full description

Bibliographic Details
Main Authors: Bergeline C. Nguemwo Tentokam, Chanaki Amaratunga, Nada A. H. Alani, Nicholas J. MacDonald, David L. Narum, Nichole D. Salinas, Jennifer L. Kwan, Seila Suon, Sokunthea Sreng, Dhelio Batista Pereira, Niraj H. Tolia, Ricardo T. Fujiwara, Lilian L. Bueno, Patrick E. Duffy, Camila H. Coelho
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Immunology
Subjects:
malaria
Plasmodium vivax
Pvs230
transmission-blocking vaccine
seroreactivity
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.02295/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2019.02295/full

Similar Items